The PRISMS study.: Interferon-β 1a (Rebif®) in intermittent multiple sclerosis

被引：0
|
作者：
Hartung, HP
Flachenecker, P
Weilbach, FX
Rieckmann, P
机构：
[1] Karl Franzens Univ Graz, Neurol Klin, A-8036 Graz, Austria
[2] Univ Wurzburg, Neurol Klin, D-8700 Wurzburg, Germany
来源：
NERVENARZT | 1999年 / 70卷 / 02期
关键词：
D O I：
10.1007/s001150050421
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：182 / 185
页数：6
相关论文
共 50 条
  • [1] The PRISMS study. Interferon-β 1a (Rebif) in intermittent multiple sclerosis [Die PRISMS-studie. Interferon-β 1a (Rebif®) bei schubformiger multipler sklerose]
    Hartung H.-P.
    Flachenecker P.
    Weilbach F.X.
    Rieckmann P.
    [J]. Der Nervenarzt, 1999, 70 (2) : 182 - 185
  • [2] The use of interferon-β-1a (Rebif®) in children and adolescents with multiple sclerosis
    Pohl, D
    Rostasy, K
    Hanefeld, E
    Gärtner, J
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S250 - S250
  • [3] Haematological Effects of Interferon-β-1a (Rebif®) Therapy in Multiple Sclerosis
    Peter Rieckmann
    Paul O’Connor
    Gordon S. Francis
    Graham Wetherill
    Enrica Alteri
    [J]. Drug Safety, 2004, 27 : 745 - 756
  • [4] Haematological effects of interferon-β-1a (Rebif®) therapy in multiple sclerosis
    Rieckmann, P
    O'Connor, P
    Francis, GS
    Wetherill, G
    Alteri, E
    [J]. DRUG SAFETY, 2004, 27 (10) : 745 - 756
  • [5] Spotlight on Subcutaneous Recombinant Interferon-β-1a (Rebif®) in Relapsing-Remitting Multiple Sclerosis
    David Murdoch
    Katherine A. Lyseng-Williamson
    [J]. BioDrugs, 2005, 19 : 323 - 325
  • [6] Spotlight on subcutaneous recombinant interferon-β-1a (Rebif®) in relapsing-remitting multiple sclerosis
    Murdoch, D
    Lyseng-Williamson, KA
    [J]. BIODRUGS, 2005, 19 (05) : 323 - 325
  • [7] Interferon β-1a (Rebif) induced regulatory pathways in multiple sclerosis
    Gurevich, M.
    Snir, Y.
    Achiron, A.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 206 - 207
  • [8] Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosis
    Cardentey Sanchez, Reinier
    Diaz de la Fe, Amado
    Pelaez Suarez, Alejandro
    Grass, Dayme
    Morgado Vega, Teresa
    Sanchez Canal, Armando
    Siniscalco, Dario
    Robinson Agramonte, Maria de los Angeles
    [J]. DRUG DEVELOPMENT RESEARCH, 2021, 82 (05) : 707 - 715
  • [9] Subcutaneous Recombinant Interferon-β-1a (Rebif®) A Review of its Use in the Treatment of Relapsing Multiple Sclerosis
    Sanford, Mark
    Lyseng-Williamson, Katherine A.
    [J]. DRUGS, 2011, 71 (14) : 1865 - 1891
  • [10] Subcutaneous Recombinant Interferon-β-1a (Rebif®)A Review of its Use in the Treatment of Relapsing Multiple Sclerosis
    Mark Sanford
    Katherine A. Lyseng-Williamson
    [J]. Drugs, 2011, 71 : 1865 - 1891
12345